These findings correlated with decreased expression of APE1/Ref-1 resulting in decreased DNA binding activity of HIF-1α and NF-κB, thereby inhibiting transcription of downstream genes essential for tumor growth and angiogenesis (118). The gene discussed is APEX1; the disease is neoplasm.